← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › AMINOGLYCOSIDE ANTIBACTERIALS › Other aminoglycosides
dibekacin
J01GB09
Forms & Strengths
- Injectable solution: 50 mg/mL
- Injectable solution: 100 mg/mL
Adult Dosing
- Intramuscular or Intravenous: 1 to 2 mg/kg body weight every 8 hours or 2 to 3 mg/kg every 12 hours
- Maximum daily dose: 3 mg/kg/day divided into 2-3 doses in patients with normal renal function
- Renal impairment: Dose reduction or interval extension required based on creatinine clearance
Pediatric Dosing
- Neonates and Infants: 1.5 to 2 mg/kg every 12 hours
- Children: 1 to 2 mg/kg every 8 hours or 2 to 3 mg/kg every 12 hours
- Dosing must be guided by therapeutic drug monitoring and renal function
Indications
- Treatment of serious infections caused by susceptible Gram-negative bacteria including Pseudomonas aeruginosa, Proteus species, Enterobacter, and Klebsiella species
- Infections of the lower respiratory tract, urinary tract, bone, skin, and intra-abdominal infections
Mechanism of Action
- Aminoglycoside antibiotic that binds irreversibly to the 30S ribosomal subunit of susceptible bacteria
- Inhibits protein synthesis, misreads bacterial genetic code, and leads to cell death
Contraindications
- Known hypersensitivity to dibekacin or other aminoglycosides
- History of severe toxic reactions to aminoglycosides
Adverse Reactions
- Nephrotoxicity (elevated serum creatinine, blood urea nitrogen, acute renal failure)
- Ototoxicity (auditory damage, vestibular toxicity, tinnitus, hearing loss)
- Neurotoxicity (neuromuscular blockade, paresthesia, muscle twitching)
- Hypersensitivity reactions (rash, urticaria, pruritus)
Drug Interactions
- Concurrent use with potent diuretics (e.g., ethacrynic acid, furosemide) increases risk of ototoxicity
- Increased risk of nephrotoxicity and ototoxicity when combined with other nephrotoxic agents (e.g., vancomycin, amphotericin B, cisplatin, polymyxins)
- Enhanced neuromuscular blockade when administered with general anesthetics, neuromuscular blocking agents, or massive blood transfusions containing citrate anticoagulant
Curated Content: Needs Vetting Before Put to Clinical Use